And in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies.
https://psychedelicspotlight.com/wp-content/uploads/2021/07/cybin_nyse_american_psychedelic_spotlight.jpg8731310Emily Jarviehttps://psychedelicspotlight.com/wp-content/uploads/2023/01/PS_LOGO_PRIMARY_DOT_WHT-1.pngEmily Jarvie2021-07-22 17:11:292021-07-22 17:11:36Cybin Receives Conditional Approval to Trade on NYSE American
Get a roundup of Psychedelic news stories in your inbox
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.